about
Oral dextrose gel for the treatment of hypoglycaemia in newborn infantsOral dextrose gel for the prevention of hypoglycaemia in newborn infantsOral dextrose gel for the treatment of hypoglycaemia in newborn infantsFas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndromeResearch advances in neonatal hypoglycemic brain injuryOutcome of neonatal hypoglycaemia. Complete data are neededEarly blood glucose profile and neurodevelopmental outcome at two years in neonatal hypoxic-ischaemic encephalopathy.Practical management of hyperinsulinism in infancyReal-time continuous glucose monitoring reduces the duration of hypoglycemia episodes: a randomized trial in very low birth weight neonates.Prediction of impaired metabolic adaptation by antenatal Doppler studies in small for gestational age fetuses.Long-term follow up of persistent hyperinsulinaemic hypoglycaemia of infancy.Long-term neurological dysfunction and neonatal hypoglycaemia after diabetic pregnancyNeonatal hypoglycaemia in Nepal 1. Prevalence and risk factors.Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.Evaluation of "point of care" devices in the measurement of low blood glucose in neonatal practice.The continuous glucose monitoring sensor in neonatal intensive careRandomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocolAnalytic characteristics of three Bayer contour blood glucose monitoring systems in neonates.In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypesHyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management.Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease.Glucose levels in newborns with special reference to hypoglycemia: a study from rural India.Hypoglycemia in critically ill children.Patterns of metabolic adaptation for preterm and term infants in the first neonatal week.Somatosensory evoked potentials and outcome in perinatal asphyxia.New insights into the nutritional management of newborn infants derived from studies of metabolic and endocrine inter-relations during the adaptation to post-natal life.An emerging evidence base for the management of neonatal hypoglycaemia.Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort StudyEvaluation of fasts for investigating hypoglycaemia or suspected metabolic diseaseGlucose for Children during Surgery: Pros, Cons, and Protocols: A Postgraduate Educational Review.Parieto-occipital encephalomalacia in children; clinical and electrophysiological features of twenty-seven cases.Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism.Neonatal hypoglycemia, part II: pathophysiology and therapy.Measuring blood glucose in neonatal units: how does hemocue compare?Prevention and management of neonatal hypoglycaemia.Evaluation of three glucometers for whole blood glucose measurements at the point of care in preterm or low-birth-weight infants.Investigation and management of congenital hyperinsulinism.Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy.A survey of the management of neonatal hypoglycaemia within the Australian and New Zealand Neonatal Network.Cost Analysis of Treating Neonatal Hypoglycemia with Dextrose Gel.
P2860
Q24185790-CD323FCE-BD0C-4094-BCAB-161901AF1CBEQ24185971-356BEB36-5D3A-4423-93D0-48E89117B556Q24198903-4216B85B-3EA4-40D8-89E0-48857C2ACF5CQ24685217-71E9591B-56DE-41F5-A378-0AA991962B48Q27005586-DCD51B07-C0C0-48B5-8B90-8282145A3588Q31934143-F4889E9A-14F3-4B90-B0C6-46AA465194ABQ33812114-1C889895-F057-4443-8D46-6293E73E7047Q33844337-1CF3E56E-D378-44B3-8E03-0D97E96A24D8Q34973228-D5DC83B3-C18E-4D88-B2FC-833083963118Q35066749-B8E1D481-8F3D-4956-B5AB-37A3F5005F51Q35261389-53C69D8E-0503-41C1-9D16-BC5CF7BCCE27Q35287559-0F6584DD-0138-44FB-BC42-836AD2697DCBQ35289045-AD75E589-CB41-407F-85F0-23D07B7D73ECQ35289892-97454C02-3FE2-4185-A692-270AD420998AQ35294965-307D0BB6-894E-431F-80C3-EEC1AE811E28Q35297175-AE48B10C-A9E2-42D5-971C-12B755341CFCQ35777990-66177BFC-37CF-4577-84D1-B034ACD18ECEQ36159127-4BD11020-6E91-4551-9A26-B9090AB54DF7Q36722478-542347B5-AFB7-4C75-8DC7-613AA61784A8Q36858615-F7F8991A-8518-4F83-B65E-1971C5A3178CQ37329261-4AD82034-0EA6-41D4-B687-400FAF822FABQ37695766-81F97BBE-12B4-4867-AB75-B53B26FE2900Q37991762-1676637E-4CA3-45C1-B735-80A7DD22CD0BQ38366544-5706D672-ABEB-4F89-ACFE-E836F026A05DQ38366560-B56D5E31-0287-4B26-BB87-9DB4DBC88C8FQ38701586-F5CC7D1F-14B0-4CEC-AFCE-DF9A4245C087Q39042672-279EDAA4-D5B8-4C00-81E4-677251294988Q40964301-BCDBC013-71AF-4371-8140-EEA1837C571FQ41163020-CFE83105-AD31-441E-A267-2930703CD02BQ41262710-E84D8135-AA97-410F-B353-96FB77E84F41Q41494555-F705BA19-9BE9-4062-9A5D-CF59EC5181B3Q41676854-5FD51AD3-5F3E-4C11-8A5E-12793D6C418BQ41707121-FE12BD0F-B9B9-4D39-8C32-49BC84141B7EQ42701760-4435372A-ED6F-4CA3-95DD-D6C739324668Q42704146-216FC22F-4CCD-4AC1-A6BB-29A52C77721AQ43161119-F559FEED-EEB4-4577-9495-A36829C8849AQ43191603-26177585-C857-4D4D-B8AF-E708D568BB72Q44083786-868F7F62-EAF9-4FEA-A067-E9C63F5DE12BQ48422512-B72998BC-3756-40B6-81DA-A75C8AF6CBE7Q52601901-F9BE0A62-D8CD-4359-8082-38D94DC34E52
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Neural dysfunction during hypoglycaemia.
@en
type
label
Neural dysfunction during hypoglycaemia.
@en
prefLabel
Neural dysfunction during hypoglycaemia.
@en
P2093
P2860
P356
P1476
Neural dysfunction during hypoglycaemia.
@en
P2093
P2860
P304
P356
10.1136/ADC.63.11.1353
P407
P577
1988-11-01T00:00:00Z